Liaoning Chengda Biotechnology Co.,Ltd.

SHSE:688739 Stock Report

Market Cap: CN¥11.2b

Liaoning Chengda BiotechnologyLtd Future Growth

Future criteria checks 0/6

Liaoning Chengda BiotechnologyLtd is forecast to grow revenue at 7.2% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth45.1%
Revenue growth rate7.2%
Future return on equity4.7%
Analyst coverage

Low

Last updated10 Sep 2024

Recent future growth updates

No updates

Recent updates

Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) Price Is Right But Growth Is Lacking

Aug 22
Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) Price Is Right But Growth Is Lacking

Some May Be Optimistic About Liaoning Chengda BiotechnologyLtd's (SHSE:688739) Earnings

Apr 29
Some May Be Optimistic About Liaoning Chengda BiotechnologyLtd's (SHSE:688739) Earnings

Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) Price Is Right But Growth Is Lacking

Apr 24
Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) Price Is Right But Growth Is Lacking

Earnings and Revenue Growth Forecasts

SHSE:688739 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,034N/A3524941
12/31/20251,867N/A2994401
12/31/20241,771N/A3355101
9/30/20241,718332175526N/A
6/30/20241,759353116547N/A
3/31/20241,761420109602N/A
12/31/20231,750466125677N/A
9/30/20231,78958895678N/A
6/30/20231,805667120659N/A
3/31/20231,802690135617N/A
12/31/20221,81571435546N/A
9/30/20221,71365366583N/A
6/30/20221,79769828573N/A
3/31/20221,859763-2572N/A
12/31/20212,088892-2506N/A
9/30/20212,069916-34414N/A
6/30/20212,138970216557N/A
3/31/20212,091942464735N/A
12/31/20201,996918671860N/A
9/30/20202,0589197921,065N/A
6/30/20201,970899610998N/A
3/31/20201,895817354774N/A
12/31/20191,677698262724N/A
9/30/20191,532713284658N/A
6/30/20191,461650381620N/A
3/31/20191,425650463637N/A
1/1/20191,391627532640N/A
9/30/20181,418612567627N/A
6/30/20181,357593N/A637N/A
3/31/20181,308579N/A688N/A
12/31/20171,276556N/A644N/A
9/30/20171,278577N/A552N/A
6/30/20171,146482N/A592N/A
3/31/20171,011429N/A484N/A
12/31/20161,030457N/A525N/A
9/30/2016925410N/A556N/A
6/30/2016904447N/A436N/A
3/31/2016924452N/A460N/A
12/31/2015943458N/A484N/A
9/30/2015964475N/A460N/A
6/30/2015978478N/A583N/A
3/31/2015957460N/A630N/A
12/31/2014937442N/A678N/A
12/31/2013851404N/A406N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 688739's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 688739's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 688739's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688739's revenue (7.2% per year) is forecast to grow slower than the CN market (14% per year).

High Growth Revenue: 688739's revenue (7.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688739's Return on Equity is forecast to be low in 3 years time (4.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y